Safety and Efficacy of Glucosanol in Reducing Body Weight in Overweight and Obese Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
Glucosanol™, the medical device to be investigated contains a proprietary plant extract that is a natural inhibitor of alpha-amylase and can reduce starch digestion. The rationale for this study is to confirm that Glucosanol™ ingestion will reduce body weight. A double-blind, randomized, placebo-controlled design has been chosen to assess the efficacy and safety of Glucosanol™ in subjects who are overweight and mildly obese.
Epistemonikos ID: 2829b22e24c01d81010f0f3d25a2d6a2834e71b3
First added on: May 06, 2024